05.16.23
The global anti-aging products market will reach $60 Billion by 2030, this according to a global market report by ResearchAndMarkets.
In the post COVID-19 business landscape, the global market for anti-aging products estimated at $38.9 billion in 2022 is projected to reach a revised $60 billion by 2030, growing at a CAGR of 5.6% over the analysis period 2022-2030.
Anti-wrinkle products— one of the segments analyzed in the report— is projected to record a 6.5% CAGR and reach $24.9 billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the anti-pigmentation products segment is readjusted to a revised 4.7% CAGR for the next eight-year period.
The US market is estimated at $13 billion, while China is forecast to grow at 7.8% CAGR over the analysis period 2022 to 2030 – a projected market size of $4.1 billion by 2030
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.7%, respectively, over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.5 Billion by the year 2030.
Select competitors include ARK Skincare; Avon Products Inc.; Bausch Health Companies Inc.; Bayer AG; Beiersdorf AG; Biomod Inc.; Chanel SA; Christian Dior SE; Clarins; Clinique Laboratories, LLC; Elizabeth Arden Inc.; Ella Bache; Estee Lauder Inc.; Henkel KGaA; Jan Marini Skin Research Inc.; Johnson & Johnson; L'Oreal SA; LR Health & Beauty Systems GmbH; Merck KGaA; NeoStrata Company, Inc.; Neutrogena Corporation; Pfizer, Inc.; Procter & Gamble; Revlon Inc.; Shiseido Co. Ltd.; and Unilever PLC.